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INTRODUCTION: Hyperpolarized MRS allows for the study of fast biochemical processes associated with cardiac workload and 
gives the ability to differentiate between normal and pathological metabolism [1,2,3,4]. Acetate has been a successful tracer in 
assessing myocardial oxidative metabolism in PET and MRS and has been suggested as a marker of myocardial viability. After 
extraction from plasma, acetate is activated to acetylCoA which crosses the 
mitochondrial membrane through the carnitine shuttle complex after which it enters 
the TCA cycle as citrate via an irreversible condensation with oxaloacetate [5,6]. The 
formation of acetylCoA and acetylcarnitine, an important shuttle and buffer of acetyl 
groups, was previously detected in vivo after the infusion of hyperpolarized acetate 
[2], which is independent of pyruvate dehydrogenase (PDH) activity. Here we report 
the in vivo measurement of the metabolic conversion of acetate to acetylcarnitine and 
citrate, a TCA cycle intermediate, in cardiac muscle and perform a kinetic analysis of 
the observed dynamics. 
 
METHODS: All in vivo studies (n = 3) were performed in healthy Sprague-Dawley 
male rats on a 9.4T/31 cm MR scanner (Varian/Magnex) using home-built 13C/1H 
surface coils. Frozen glassy beads containing [1-13C]acetate (4.5M) and TEMPO free 
radical (33mM) were dynamically polarized for 2 h [7], dissolved and transferred to 
an infusion pump within 2 s, and, 1 s later,  1 mL of the resulting hyperpolarized 
solution was automatically injected into a femoral vein within 5 s. MR acquisition 
started 3 s after the beginning of the infusion. The entire process including 
dissolution, transfer and MR acquisition was automated. Spectra were recorded using 
B1-insensitive 30° adiabatic RF pulses to ensure the same excitation for the substrate 
and the observed metabolites and 1H decoupling was applied during the acquisition. 
The measurements were performed with a repetition time of 3 s and triggered on the 
respiration and the cardiac cycle. 
 
RESULTS AND DISCUSSION: The metabolic time courses of hyperpolarized 
acetate (182.6 ppm) and its metabolic products citrate (179.7 ppm) and acetylcarnitine 
(173.9 ppm) were recorded in healthy myocardium in vivo. A spectrum is shown in 
Fig. 1. Using the FASTMAP shimming protocol, 1H line widths of 20 to 30 Hz were 
obtained in a voxel size of 4x6x6 mm3. The observed 13C FWHM measured during 
the hyperpolarized MR experiments were between 30 and 40 Hz (localization 
achieved by placing the surface coil on top of the mouse heart). Peak areas were 
extracted using jMRUI and the time courses are displayed in Fig. 3. The maximum 
peak integral of acetate was observed 9 s after the beginning of the infusion, the 
maximum acetylcarnitine about 12 s later and the maximum citrate approximately 6 s 
after acetylcarnitine. This observation supports the role of carnitine as a shuttle for 
acetyl groups across the mitochondrial membrane. A three-compartment non steady-
state metabolic model (Fig. 2) was used to fit the metabolic time courses. This model 
takes into account the effect of repeated excitations and contains 4 free parameters 
(RAce, kAce-Acc, kAcc-Cit, RCit). The kinetic rate constant kAcc-Cit is representative for TCA 
cycle activity and thus myocardial oxidation. The T1 relaxation time of [1-
13C]acetylcarnitine in blood was measured to be 14.9 s and used as a constant. The result of this fit is displayed in Fig. 3, with kinetic 
parameters kAce-Acc = 1.5 ± 0.2 ms-1, kAcc-Cit = 21 ± 4.5 ms-1.  
 
CONCLUSION: We conclude that by using hyperpolarized [1-13C]acetate it is possible to study the in vivo real-time formation of 
acetylcarnitine and TCA cycle intermediates and thus directly measure energy metabolism in healthy myocardium. This method could 
be applied to study models of cardiac ischemia-reperfusion.  
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Fig. 1: Sum of 4 spectra (t = 21 s to 30 s). 
Acetate and two metabolic products (citrate 
and acetylcarnitine) were observed. 
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Fig. 2: Three-compartment model equations
 
Fig. 3: Extracted peak areas from a typical 
experiment were normalized to their 
maximum and are displayed from the time 
of the injection. The extracted peak areas 
were fit to the three-compartment metabolic 
model (see Fig.2) to extract the kinetic 
parameters of the conversions.  
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